Loading clinical trials...
Loading clinical trials...
Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care Due to Coronavirus Disease 2019 (COVID-19)- Randomised Controlled Trial
Conditions
Interventions
Azithromycin
Hydroxychloroquine
+1 more
Locations
1
Czechia
František Duška
Prague, Česká Republika, Czechia
Start Date
May 13, 2020
Primary Completion Date
November 4, 2020
Completion Date
November 4, 2020
Last Updated
November 6, 2020
NCT06082518
NCT07221162
NCT06631287
NCT06679140
NCT06417762
NCT03830320
Lead Sponsor
Frantisek Duska, MD, PhD
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions